ABC294640 is an orally available, aryladamantane compound and selective inhibitor of sphingosine kinase-2 (SK2) with potential antineoplastic activity. Upon administration, ABC294640 competitively binds to and inhibits SK2, thereby preven
1.Lewis CS, Voelkel-Johnson C, Smith CD. (2018) Targeting Sphingosine Kinases for the Treatment of Cancer.. Adv Cancer Res, 140 (13):(295-325). [PMID:30060814][10.1021/op500134e]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.